<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.belgiumhealthreview.com/article/909437639-nyxoah-to-participate-in-the-bank-of-america-2026-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Belgium Health Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T20:05:00+00:00</news:publication_date>
        <news:title>Nyxoah to Participate in the Bank of America 2026 Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/logo-nyxoah-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.belgiumhealthreview.com/article/909437652-nyxoah-participera-la-conf-rence-bank-of-america-2026-healthcare</loc>
      <news:news>
        <news:publication>
          <news:name>Belgium Health Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T20:05:00+00:00</news:publication_date>
        <news:title>Nyxoah Participera à la Conférence Bank of America 2026 Healthcare</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.belgiumhealthreview.com/article/909377197-confo-therapeutics-announces-phase-2-clinical-trial-initiation-by-lilly-for-peripheral-pain-candidate-cftx-1554</loc>
      <news:news>
        <news:publication>
          <news:name>Belgium Health Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T15:30:00+00:00</news:publication_date>
        <news:title>Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/a9fcac03-0dcc-4a7b-b073-1b8fe4c6cf72/small/2026-confo-logo-png.png</image:loc>
        </image:image>
    </url>
</urlset>
